- Merck & Co. (Rahway, NJ)
- …and vaccines for the benefit of patients and global human health.The Associate Vice President (AVP), Late Development Statistics, BARDS, is responsible and ... support for a number our company's late-stage products in Oncology . The AVP will work under the direction of...work under the direction of the Late Development Statistics Vice President in BARDS and will work… more
- Regeneron Pharmaceuticals (Tarrytown, NY)
- The Global Program Head (GPH) for Oncology drives the creation of an integrated program strategy through engaging with and including information from all relevant ... to authorize final program strategy decisions. Lastly, the GPH co-leads the asset strategic team and with their clinical co-leader, is responsible for program… more
- Regeneron Pharmaceuticals (Tarrytown, NY)
- …areas on areas and assets of intersection -Inflammation and Immunology, Neuroscience, Oncology etc. This is a critical strategic and execution role that will ... Program Heads (GPH) that owns the entire life cycle for each asset . Creating asset development strategy, including the clinical development strategy, is led by… more
- Merck (Rahway, NJ)
- …vaccines for the benefit of patients and global human health. The Associate Vice President (AVP), Late Development Statistics, BARDS, is responsible and ... support for a number our company's late-stage products in Oncology . The AVP will work under the direction of...work under the direction of the Late Development Statistics Vice President in BARDS and will work… more
- Gilead Sciences, Inc. (Parsippany, NJ)
- …co. Gilead is a patient centric, science focused company. Reporting to the Vice President , Global Medical Strategy and Operations, this individual is responsible ... of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions,...drugs includes treatments for HIV/AIDS, COVID, HBV, HCV, HDV, Oncology and Cell Therapy as well as Inflammatory Diseases… more
